177 related articles for article (PubMed ID: 29182998)
1. Three newly identified lipophilic flavonoids in Tanacetum parthenium supercritical fluid extract penetrating the Blood-Brain Barrier.
Végh K; Riethmüller E; Hosszú L; Darcsi A; Müller J; Alberti Á; Tóth A; Béni S; Könczöl Á; Balogh GT; Kéry Á
J Pharm Biomed Anal; 2018 Feb; 149():488-493. PubMed ID: 29182998
[TBL] [Abstract][Full Text] [Related]
2. Rapid extraction and high-performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium).
Zhou JZ; Kou X; Stevenson D
J Agric Food Chem; 1999 Mar; 47(3):1018-22. PubMed ID: 10552409
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
4. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro.
Brown AM; Edwards CM; Davey MR; Power JB; Lowe KC
J Pharm Pharmacol; 1997 May; 49(5):558-61. PubMed ID: 9178194
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-HSV-1 activity and toxicity of hydroethanolic extract of Tanacetum parthenium (L.) Sch.Bip. (Asteraceae).
Benassi-Zanqueta É; Marques CF; Valone LM; Pellegrini BL; Bauermeister A; Ferreira ICP; Lopes NP; Nakamura CV; Dias Filho BP; Natali MRM; Ueda-Nakamura T
Phytomedicine; 2019 Mar; 55():249-254. PubMed ID: 30668436
[TBL] [Abstract][Full Text] [Related]
7. Convergence chromatographic determination of camphor in the essential oil of Tanacetum parthenium L.
Végh K; Riethmüller E; Tóth A; Alberti Á; Béni S; Balla J; Kéry Á
Biomed Chromatogr; 2016 Dec; 30(12):2031-2037. PubMed ID: 27324458
[TBL] [Abstract][Full Text] [Related]
8. A biologically active lipophilic flavonol from Tanacetum parthenium.
Williams CA; Hoult JR; Harborne JB; Greenham J; Eagles J
Phytochemistry; 1995 Jan; 38(1):267-70. PubMed ID: 7766058
[TBL] [Abstract][Full Text] [Related]
9. Attempts of chemical standardizing of Chrysanthemum parthenium as a prospective antimigraine drug.
Gromek D; Kisiel W; Stojakowska A; Kohlmünzer S
Pol J Pharmacol Pharm; 1991; 43(3):213-7. PubMed ID: 1961694
[TBL] [Abstract][Full Text] [Related]
10. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
11. Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species.
Hausen BM; Osmundsen PE
Acta Derm Venereol; 1983; 63(4):308-14. PubMed ID: 6195862
[TBL] [Abstract][Full Text] [Related]
12. Identification of antioxidant phenolic compounds in feverfew (Tanacetum parthenium) by HPLC-ESI-MS/MS and NMR.
Wu C; Chen F; Wang X; Wu Y; Dong M; He G; Galyean RD; He L; Huang G
Phytochem Anal; 2007; 18(5):401-10. PubMed ID: 17624900
[TBL] [Abstract][Full Text] [Related]
13. Bioassay-guided isolation of apigenin with GABA-benzodiazepine activity from Tanacetum parthenium.
Jäger AK; Krydsfeldt K; Rasmussen HB
Phytother Res; 2009 Nov; 23(11):1642-4. PubMed ID: 19441011
[TBL] [Abstract][Full Text] [Related]
14. Quantitative estimation of parthenolide in Tanacetum parthenium (L.) Schultz-Bip. cultivated in Egypt.
El-Shamy AM; El-Hawary SS; Rateb ME
J AOAC Int; 2007; 90(1):21-7. PubMed ID: 17373433
[TBL] [Abstract][Full Text] [Related]
15. Quantification of parthenolide in Tanacetum species by LC-UV/LC-MS and microscopic comparison of Mexican/US feverfew samples.
Avula B; Navarrete A; Joshi VC; Khan IA
Pharmazie; 2006 Jul; 61(7):590-4. PubMed ID: 16889065
[TBL] [Abstract][Full Text] [Related]
16. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties.
Williams CA; Harborne JB; Geiger H; Hoult JR
Phytochemistry; 1999 Jun; 51(3):417-23. PubMed ID: 10382317
[TBL] [Abstract][Full Text] [Related]
17. Aldose Reductase, Protein Glycation Inhibitory and Antioxidant of Peruvian Medicinal Plants: the Case of Tanacetum parthenium L. and Its Constituents.
Hwang SH; Kim HY; Quispe YNG; Wang Z; Zuo G; Lim SS
Molecules; 2019 May; 24(10):. PubMed ID: 31130646
[TBL] [Abstract][Full Text] [Related]
18. Bioactive flavonoids of Tanacetum parthenium revisited.
Long C; Sauleau P; David B; Lavaud C; Cassabois V; Ausseil F; Massiot G
Phytochemistry; 2003 Sep; 64(2):567-9. PubMed ID: 12943776
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
